Olysio (Simeprevir) Capsules
Generic name : Simeprevir.
Trade name : Olysio.
Manufacturer information :
Olysio is manufactured by Janssen Pharmaceuticals, Inc.
Olysio FDA Approval :
Olysio first approved November 22nd, 2013.
Olysio Dosage form :
Capsule: 150 mg
Olysio Indications and Usage :
Chronic Hepatitis C
Indicated for treatment of chronic hepatitis C genotype 1 infection as a component of a combination antiviral treatment regimen.
Olysio (Simeprevir) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.